Literature DB >> 26165710

Can prosthesis design of total knee arthroplasty affect balance?

Mehmet İsyar1, İlknur Saral, Olcay Güler, Engin Çakar, Mahir Mahiroğullari.   

Abstract

OBJECTIVES: In this study, we aimed to investigate whether posterior cruciate ligament (PCL) retaining or substituting in total knee arthroplasty affect the balance. PATIENTS AND METHODS: Between March 2010 and April 2014, a total of 41 patients who underwent total knee arthroplasty in our clinic were included in the study. A PCL-substitution prosthesis was used in 21 patients (group 1) and a PCL-retaining prosthesis was used in 20 patients (group 2). Balance and fall risk were evaluated using a balance assessment device. The patients were examined by the Berg Functional Balance Scale.
RESULTS: The mean follow-up was 25.6±9.7 months. There was no statistically significant difference in static or dynamic overall stability, mediolateral stability or fall risk between the two types of prostheses. A significant difference in the dynamic anteroposterior stability index scores was observed between the groups.
CONCLUSION: Our study results show that PCL-substitution prosthesis affects the balance positively in total knee arthroplasty. Therefore, PCL-substitution prosthesis design should be considered for patients who have risk factors for balance disorder, in particular.

Entities:  

Mesh:

Year:  2015        PMID: 26165710     DOI: 10.5606/ehc.2015.18

Source DB:  PubMed          Journal:  Eklem Hastalik Cerrahisi


  2 in total

1.  Baropodometry on patients after total knee arthroplasty.

Authors:  A Notarnicola; G Maccagnano; A Fiore; A Spinarelli; L Montenegro; M Paoloni; F Pastore; S Tafuri; B Moretti
Journal:  Musculoskelet Surg       Date:  2017-10-03

2.  Posterior cruciate-retaining versus posterior-stabilized total knee arthroplasty for osteoarthritis with severe varus deformity.

Authors:  Ethem Ayhan Ünkar; Yusuf Öztürkmen; Erhan Şükür; Engin Çarkçı; Murat Mert
Journal:  Acta Orthop Traumatol Turc       Date:  2017-01-17       Impact factor: 1.511

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.